DNAVision
ActiveFrom the official registers: KBO 22 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of DNAVision is 2.1% (moderate). The 2025 annual accounts show negative equity (-€879,841) and a net result of -€73,752. Equity is shrinking by about 13% per year across the filed financial years. Its solvency ranks better than 5% of 239 sector peers (NACE 72, financial year 2025). The company has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
21-09
financial year 2025 · full format · 52 days late
2025
19-09
financial year 2024 · full format · 50 days late
2024
29-08
financial year 2023 · full format · 29 days late
2023
31-08
financial year 2022 · full format · 31 days late
2022
13-10
financial year 2021 · full format · 74 days late
2021
21-12
financial year 2020 · full format · 143 days late
2020
31-12
Financial
Weakest financial yearnet -€234,691
Net result drops to -€234,691, the lowest in the series; recovery starts the following year.
30-11
financial year 2019 · full format · 122 days late
2019
2018
09-03
financial year 2016 · full format · 221 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank